# Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

> **NCT01578304** · PHASE4 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 207 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Imidafenacin
- **DRUG:** Fesoterodine

## Key facts

- **NCT ID:** NCT01578304
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2012-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578304, "Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01578304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*